Short answer: apolipoprotein B, or ApoB, is a blood marker that approximates the number of atherogenic lipoprotein particles. Each LDL particle and several other particles capable of entering the artery wall carries one ApoB molecule. ApoB can therefore reveal particle burden that an LDL cholesterol result may sometimes underestimate.
ApoB is not a complete heart-risk score and is not necessary in every situation. It is most useful when a clinician has a defined question, especially when LDL-C, non-HDL-C, triglycerides, diabetes or other metabolic factors do not tell a consistent story.
Key takeaway: LDL-C measures the cholesterol carried inside LDL particles; ApoB approximates how many atherogenic particles are circulating. Both can be useful, but they are not interchangeable.
Table of contents
- What is ApoB?
- Why particle number matters
- ApoB versus LDL cholesterol
- ApoB versus non-HDL cholesterol
- What does discordance mean?
- Who may benefit from testing?
- What athletes should know
- AAS, PEDs and ApoB
- How the test is performed
- How to interpret a result
- How ApoB is lowered
- Frequently asked questions
- References
What is ApoB?
Apolipoproteins are proteins carried on lipoprotein particles. The main form measured in cardiovascular assessment is ApoB-100. One molecule is present on each very-low-density lipoprotein, intermediate-density lipoprotein, LDL and lipoprotein(a) particle.
These particles can enter the artery wall and contribute to atherosclerosis. Because there is one ApoB molecule per particle, the blood concentration approximates the total number of atherogenic particles.
Chylomicrons carry ApoB-48 rather than ApoB-100. Standard clinical ApoB testing largely reflects the atherogenic particle population relevant to long-term cardiovascular risk.
Why particle number matters
Atherosclerosis begins when ApoB-containing particles enter and become retained in the artery wall. More circulating particles create more opportunities for that retention over time. Blood pressure, smoking, diabetes, inflammation and other factors affect the overall process, but atherogenic particle exposure is central.
Imagine two vehicles carrying the same total cargo:
- one person may have fewer cholesterol-rich LDL particles; and
- another may have more cholesterol-depleted LDL particles.
LDL-C could appear similar because the total cholesterol cargo is similar. ApoB would be higher in the person with more particles.
ApoB versus LDL cholesterol
| Marker | What it estimates | Main strength |
|---|---|---|
| LDL-C | Cholesterol mass inside LDL particles | Widely available, well studied and a primary treatment target |
| ApoB | Number of LDL and other atherogenic particles | Can clarify particle burden when cholesterol content varies |
ApoB does not make LDL-C obsolete. LDL-C remains clinically useful and central to guidelines. ApoB can refine interpretation in selected people, particularly when the two markers are discordant.
ApoB versus non-HDL cholesterol
Non-HDL-C is total cholesterol minus HDL-C. It captures cholesterol carried across LDL and other ApoB-containing particles. Unlike ApoB, it measures the cholesterol cargo rather than particle count.
Non-HDL-C has the advantage of being available from a standard lipid panel at no extra assay cost. ApoB may provide greater clarity when triglycerides are high, metabolic risk is present or the average cholesterol carried per particle differs substantially.
What does discordance mean?
Discordance means two related markers fall into meaningfully different population percentiles or risk categories. It does not mean comparing their raw numbers, because LDL-C and ApoB use different units and scales.
Common examples include:
- discordantly high ApoB: particle number is higher than LDL-C would suggest;
- discordantly low ApoB: fewer particles carry more cholesterol per particle; and
- concordance: LDL-C and ApoB tell a broadly similar story.
Systematic reviews and consensus documents report that when ApoB and LDL-C are discordant, cardiovascular risk often tracks more closely with ApoB or non-HDL-C. This should be applied clinically, not used as a reason to ignore LDL-C.
Who may benefit from testing?
A clinician may consider ApoB when there is:
- high triglycerides;
- diabetes, insulin resistance or metabolic syndrome;
- obesity or central adiposity;
- a low or moderate LDL-C that appears inconsistent with the wider risk;
- known cardiovascular disease or high baseline risk;
- lipid-lowering treatment where residual particle burden matters;
- AAS/PED exposure associated with adverse lipids; or
- a need to clarify an unusual standard lipid panel.
Testing everyone repeatedly is not necessarily useful. Ask what decision the result would change.
What athletes should know
Fitness and visible leanness do not guarantee low ApoB. Genetics, saturated-fat intake, a very-low-carbohydrate diet, rapid mass gain, medicines and PED exposure can all influence atherogenic particles.
Athletes sometimes focus on a favourable triglyceride-to-HDL ratio and assume that LDL-related risk no longer matters. Ratios can add context, but they do not count ApoB particles and should not be used to dismiss a high ApoB result.
Read cholesterol explained for athletes for the broader marker guide and the lipid-panel guide for report interpretation.
AAS, PEDs and ApoB
Prospective and observational research in AAS users has reported higher LDL-C and ApoB alongside lower HDL-C. The size of the effect varies by compound, dose, route, duration, genetics, diet and other drug exposure.
A normal ApoB does not make AAS use safe. AAS can affect blood pressure, haematocrit, heart structure, rhythm and coronary plaque through pathways not captured by ApoB. Conversely, an adverse ApoB result should not be managed only with a supplement while the suspected exposure continues unchanged.
Use steroids and cholesterol for exposure-specific detail and the enhanced-athlete heart-health guide for the full monitoring context.
How the test is performed
ApoB is measured from a blood sample and often does not require fasting. Fasting may still be requested because other tests are being collected or triglycerides need a standardised assessment. Follow the pathology instructions.
Australian laboratories may report ApoB in g/L, while international content may use mg/dL. Do not compare raw values across unit systems without a correct conversion. Use the laboratory's units and the clinician's treatment framework.
How to interpret a result
There is no universal target for every athlete. Targets depend on total cardiovascular risk, established disease, diabetes, kidney health, family history and current treatment. A laboratory reference range is not the same as an individual treatment goal.
Review:
- ApoB together with LDL-C, non-HDL-C and triglycerides;
- Lp(a) where it has been measured;
- blood pressure, smoking, diabetes and kidney function;
- family history of premature cardiovascular disease;
- medicine and AAS/PED exposure; and
- change from a comparable baseline.
How ApoB is lowered
Interventions that reduce the number of atherogenic particles generally lower ApoB. Depending on the cause and risk, these may include:
- replacing saturated fat with unsaturated fat;
- increasing soluble fibre;
- managing excess body fat and metabolic health;
- reducing alcohol where triglycerides are high;
- stopping smoking;
- reducing or stopping AAS/PED exposure that worsens the pattern; and
- statins, ezetimibe, PCSK9-targeting therapies or other medicines when clinically indicated.
The guide to how athletes can improve cholesterol provides a practical evidence-led framework. Supplements such as citrus bergamot or pantethine may modestly change lipid markers in some people, but the evidence is weaker than for established treatment and they should not replace it.
Frequently asked questions
What does ApoB measure?
ApoB concentration approximates the number of LDL and other atherogenic lipoprotein particles in the blood.
Is ApoB better than LDL cholesterol?
It answers a different question. LDL-C measures cholesterol cargo, while ApoB approximates particle number. ApoB can add information when the markers are discordant.
Do athletes need an ApoB test?
Not automatically. It may be useful with high triglycerides, metabolic risk, an unusual lipid pattern, AAS exposure or a clinician-defined risk question.
Does ApoB require fasting?
Often it does not, but fasting may be requested for the accompanying lipid or glucose tests. Follow the pathology instructions.
What units are used for ApoB in Australia?
Australian laboratories commonly use g/L. International sources may use mg/dL, so check units before comparing values.
Can ApoB be high when LDL is normal?
Yes. More cholesterol-depleted atherogenic particles can produce a higher ApoB than the LDL-C value appears to suggest.
Can high HDL cancel high ApoB?
No. HDL-C does not neutralise exposure to a high number of atherogenic particles.
Can steroids raise ApoB?
AAS can raise ApoB and LDL-C while lowering HDL-C. The response varies, and a normal ApoB does not make AAS use safe.
Can supplements lower ApoB?
Some diet and supplement interventions can modestly affect atherogenic lipids, but persistent or high-risk elevations may require evidence-based medicine and addressing the cause.
References and further reading
- National Lipid Association expert consensus on ApoB
- Systematic review of ApoB, LDL-C and non-HDL-C as risk markers
- ApoB and LDL-C discordance in young adults and coronary calcification
- National Heart Foundation of Australia: Manage high blood cholesterol
This article provides general education and does not interpret an individual ApoB result. Discuss testing and treatment targets with a qualified health professional.